Home » US Appeals Court Says No to Teva’s Generic Evista
US Appeals Court Says No to Teva’s Generic Evista
Eli Lilly & Co. won a patent battle protecting its osteoporosis drug Evista Wednesday, as an appeals court declined to toss out a permanent injunction preventing production of a generic copy of the medicine.
CNNMoney
CNNMoney
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May